Korro Bio, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-76.1M | $-79.0M | $2.9M | $21.8M |
| FY2022 | $-53.6M | $-58.8M | $5.1M | $19.8M |
| FY2023 | $-67.3M | $-75.1M | $7.8M | — |
| FY2024 | $-60.1M | $-78.0M | $17.9M | — |
| FY2025 | $-78.6M | $-79.1M | $518.0K | — |